Structured Relapse Prevention Program for Chinese Patients in Hong Kong with Comorbidity of Substance Use and Mental Health Disorders: A Feasibility Study

References

• Annis, H. M., M. A. Herie, and L. Watkin-Merek. 2006. Structured relapse prevention an outpatient counseling approach. 2nd ed. Toronto: Centre for Addiction and Mental Health.
   Google Scholar
• Barrowclough, C., G. Haddock, T. Wykes, R. Beardmore, P. Conrod, T. Craig, L. Davies, G. Dunn, E. Eisner, S. Lewis, et al. 2010. Integrated motivational interviewing and cognitive behavioral therapy for people with psychosis and comorbid substance misuse: Randomized controlled trial. BMJ 341:1–12. doi:10.1136/bmj.c6325.
   Google Scholar
• Bell, M. L., N. J. Horton, H. Dhillon, V. J. Bray, and J. Vardy. 2018. Using generalized estimating equations and extensions in randomized trials with missing longitudinal patient reported outcome data. Psycho-Oncology 27:2125–31. doi:10.1002/pon.4777.
   PubMed Web of Science ®Google Scholar
• Bellack, A. S., M. E. Bennett, J. S. Gearon, C. H. Brown, and Y. Yang. 2006. A randomized clinical trial of a new behavioral treatment of drug abuse in people with severe and persistent mental illness. Archives of General Psychiatry 63:426–32. doi:10.1001/archpsyc.63.4.426.
   PubMed Web of Science ®Google Scholar
• Bradley, A. C., A. Baker, and T. J. Lewin. 2007. Group intervention for coexisting psychosis and substance use disorders in rural Australia: Outcomes over 3 years. Australian and New Zealand Journal of Psychiatry 41:501–08. doi:10.1080/00048670701332300.
   PubMed Web of Science ®Google Scholar
• Brown, S. A., S. V. Glasner-Edwards, S. R. Tate, J. R. McQuaid, J. Chalekian, and E. Granholm. 2006. Integrated cognitive behavioral therapy versus twelve-step facilitation for substance-dependent adults with depressive disorders. Journal of Psychoactive Drugs 38 (4):449–60. doi:10.1080/02791072.2006.10400584.
   PubMed Web of Science ®Google Scholar
• Central Registry of Drug Abuse (CRDA). 2014. Narcotics Division, Security Bureau, Hong Kong. www.nd.gov.hk.
   Google Scholar
• Crippa, J. A. S., R. F. Sanches, J. E. C. Hallak, S. R. Loureiro, and A. W. Zuardi. 2001. A structured interview guide increases Brief Psychiatric Rating Scale reliability in raters with low clinical experience. ACTA Psychiatrica Scandinavica 103:465–70. doi:10.1034/j.1600-0447.2001.00185.x.
   PubMed Web of Science ®Google Scholar
• Diagnostic and statistical manual of mental disorders, fifth edition (DSM-V). 2013. United States: American Psychiatric Association. https://www.verywellmind.com/dsm-5-criteria-for-substance-use-disorders-21926.
   Google Scholar
• Douaihy, A. B., T. M. Kelly, and C. Sullivan. 2013. Medications for substance use disorders. Social Work and Public Health 28:264–78. doi:10.1080/19371918.2013.759031.
   PubMed Web of Science ®Google Scholar
• Drake, R. E., M. A. Wallach, and M. P. McGovern. 2005. Future directions in preventing replapse to substance abuse among clients with severe mental illnesses. Psychiatric Services 56 (10):1297–302. doi:10.1176/appi.ps.56.10.1297.
   PubMed Web of Science ®Google Scholar
• Guangzhou Wondfo Biotech Co., Limited. Accessed June1, 2019. https://www.companiess.com/guangzhou_wondfo_biotech_co_ltd_info1280527.html.
   Google Scholar
• Hodges, J., and T. O. S. Oei. 2007. Would confucius benefit from psychotherapy? The compatibility of cognitive behaviour therapy and Chinese values. Behaviour Research and Therapy 45 (2007):901–14. doi:10.1016/j.brat.2006.08.015.
   PubMedGoogle Scholar
• Horsfall, J., M. Cleary, G. E. Hunt, and G. Walter. 2009. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (Dual diagnosis): A review of empirical evidence. Psychosocial Treatments for Dual Diagnoses 17 (1):24–34.
   Google Scholar
• Jones, S. H., C. Barrowclough, R. Allott, C. Day, P. Earnshaw, and I. Wilson. 2011. Integrated motivational interviewing and cognitive-behavioural therapy for bipolar disorder with comorbid substance use. Clinical Psychology and Psychotherapy 18:426–37. doi:10.1002/cpp.v18.5.
   PubMed Web of Science ®Google Scholar
• Kiluk, B. D., K. A. Devore, M. B. Buck, C. Nich, T. L. Frankforter, D. M. LaPaglia, B. T. Yates, M. A. Gordon, and K. M. Carroll. 2016. Randomized trial of computerized cognitive behavioural therapy for alcohol use disorders: Efficacy as a virtual stand-alone and treatment add-on compared with standard outpatient treatment. Alcoholism: Clinical and Experimental Research 40 (9):1999–2000. doi:10.1111/acer.13162.
   Web of Science ®Google Scholar
• Kleber, H. D. 2007. Pharmacologic treatments for opioid dependence: Detoxification and maintenance options. Dialogues in Clinical Neuroscience 9 (4):455–70.
   PubMedGoogle Scholar
• Lancaster, G. A., S. Dodd, and P. R. Williamson. 2004. Design and analysis of pilot studies: Recommendations for good practice. Journal of Evaluation in Clinical Practice 10 (2):307–12. doi:10.1111/jep.2004.10.issue-2.
   PubMed Web of Science ®Google Scholar
• Lee, C. M., C. Neighbors, and B. A. Woods. 2007. Marijuana motives: Young adults’ reasons for using marijuana. NIH Public Access 32 (7):1384–94.
   Google Scholar
• Leung, J. C. W. 2015. Dual psychiatric diagnosis in substance abuse patients. Hong Kong Practitioner 37:135–42.
   Google Scholar
• Lin, Y. N. 2001. The application of cognitive-behavioral therapy to counseling Chinese. American Journal of Psychotherapy 55 (4):46–58.
   Google Scholar
• Marlatt, G. A., and J. R. Gordon. 1985. Relapse prevention. New York, NY: Guilford Press.
   Google Scholar
• Martino, S., K. Carroll, D. Kostas, J. Perkins, and B. Rounsaville. 2002 Dec. Dual diagnosis motivational interviewing: A modification of motivational interviewing for substance-abusing patients with psychotic disorders. Journal of Substance Abuse Treatment 23(4):297–308. doi: 10.1016/S0740-5472(02)00295-7.
   PubMed Web of Science ®Google Scholar
• McHugh, R. K., and S. F. Greenfield. 2010. Psychiatric symptoms improvement in women following group substance abuse treatment: Results from the women’s recovery group study. Journal of Cognitive Psychotherapy 24 (1):26–36. doi:10.1891/0889-8391.24.1.26.
   PubMedGoogle Scholar
• Milios, R. 2017. Common high risk situations in recovery and how to manage them. Accessed June 1, 2019. https://www.recovery.org/pro/articles/common-high-risk-situations-in-recovery-and-how-to-manage-them/.
   Google Scholar
• Miller, W.R., and S. Rollinck. 2012. Motivational interviewing: helping people change. 3rd ed. New York: Guilford Press.
   Google Scholar
• Overall, J. E., and D. R. Gorham. 1988. The Brief Psychiatric Rating Scale (BPRS): Recent developments in ascertainment and scaling. Psychopharmacology Bulletin. 24:97–99. Accessed May 22, 2019. http://www.psychiatrictimes.com/clinical-scales/schizophrenia/.
   Web of Science ®Google Scholar
• Ross, S., and E. Peselow. 2012. Co-occurring psychotic and addictive disorders: Neurobiology and diagnosis. Clinical Neuropharmacology 35 (5):235–43. doi:10.1097/WNF.0b013e318261e193.
   PubMed Web of Science ®Google Scholar
• Sklar, S. M., H. M. Annis, and N. E. Turner. 1997. Development and validation of the drug taking confidence questionnaire: A measure of coping self-efficacy. Addictive Behaviors 22:655–70. doi:10.1016/S0306-4603(97)00006-3.
   PubMed Web of Science ®Google Scholar
• Smith, J., and S. Hucker. 1994. Schizophrenia and substance abuse. British Journal of Psychiatry 165:13–21. doi:10.1192/bjp.165.1.13.
   PubMed Web of Science ®Google Scholar
• Spears, C. A., D. Hedeker, L. Li, C. Wu, N. K. Anderson, S. C. Houchins, C. Vinci, D. S. Hoover, J. I. Vidrine, P. M. Cinciripini, et al. 2017. Mechanisms underlying mindfulness-based addiction treatment versus cognitive behavioral therapy and usual care for smoking cessation. Journal of Consulting and Clinical Psychology 85 (11):1029–40. doi:10.1037/ccp0000229.
   PubMed Web of Science ®Google Scholar
• Substance Abuse Clinic. 2009. Narcotics Division, Security Bureau, The Government of the Hong Kong Special Administrative Region. Accessed June 14, 2018. https://www.nd.gov.hk/en/6.htm.
   Google Scholar
• Tam, C. H. L., S. I. Kwok, T. W. Lo, S. H. P. Lam, and G. K. W. Lee. 2018. Hidden drug abuse in Hong Kong: From social acquaintance to social isolation. Frontiers in Psychiatry 9:457. doi:10.3389/fpsyt.2018.00457.
   PubMed Web of Science ®Google Scholar
• To, B. 2017 Marijuana as medicine? Varsity Accessed December 1, 2017. http://varsity.com.cuhk.edu.hk/index.php/2017/12/medical-marijuana-legistration.
   Google Scholar
• Trigo, J. M., A. Soliman, L. C. Quilty, B. Fischer, J. Rehm, P. Selby, A. J. Barnes, M. A. Huestis, T. P. George, D. L. Streiner, et al. 2018 Jan 31. Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial. PLoS One 13 (1):e0190768. doi:10.1371/journal.pone.0190768.
   PubMed Web of Science ®Google Scholar
• UNODC 2017. United Nations Office on Drugs and Crime: World Drug Report 2017. Austria: United Nations Publication. Accessed June 1, 2019. https://www.unodc.org/wdr2017/field/Booklet_1_EXSUM.pdf.
   Google Scholar
• Vasconcelos, S. C., E. B. Sougey, I. da Silva Frazão, N. E. Turner, V. P. Ramos, and M. D. da Costa Lima. 2016. Cross-cultural adaptation of the drug-taking confidence questionnaire drug version for use in Brazil. BMC Medical Research Methodology 16:55. doi:10.1186/s12874-016-0153-z.
   PubMed Web of Science ®Google Scholar
• Volkow, N. D. 2001. Drug abuse and mental illness: Progress in understanding comorbidity. The American Journal of Psychiatry. Published online. doi:10.1176/appi.ajp.158.8.1181.
   Web of Science ®Google Scholar
• William, R. M., and S. Rollick. 2012. Motivational interviewing: Helping people change. 3rd ed. New York, NY: The Guilford Press.
   Google Scholar
• Witkiewitz, K., and G. A. Marlatt. 2004. Relapse prevention for alcohol and drug problems: That was Zen, this is tao. American Psychologist 59 (4):224–35. doi:10.1037/0003-066X.59.4.224.
   PubMed Web of Science ®Google Scholar
• World Health Organisation (WHO). 2004. Neuroscience of psychoactive substance use and dependence. Geneva: World Health Organisation.
   Google Scholar
• Xie, H., G. J. McHugo, M. B. Fox, and R. E. Drake. 2005. Substance abuse relapse in a ten-year prospective follow-up of clients with mental and substance use disorders. Psychiatric Services 56 (10):1282–87. doi:10.1176/appi.ps.56.10.1282.
   PubMed Web of Science ®Google Scholar
• Xu, K., and R. H. Lipsky. 2015. Repeated ketamine administration alters N-methyl-D-aspartic acid receptor subunit gene expression: implication of genetic vulnerability for ketamine abuse and ketamine psychosis in humans. Experimental Biology and Medicine 240:145-155. doi: 10.1177/1535370214549531.
   PubMed Web of Science ®Google Scholar